Since 1995, Reliable Business Intelligence for Clinical Laboratories, Pathology Groups and Laboratory Diagnostics

Search

TAG:

aco

Exome Sequencing Next “Big Thing” for Diagnosis

CEO SUMMARY: For disease diagnostics, exome sequencing is not yet routine, but geneticists are getting close. Using this technology, researchers read those parts of the human genome where about 85% of disease-causing mutations reside. By looking only at the regions that encode proteins—…

Read More



Today’s Lab Test Model Won’t Survive Reforms

CEO SUMMARY: For more than three decades, independent lab companies have waxed fat by increasing their respective market share of lab test referrals from office-based physicians. This era is poised to end as growing numbers of office-based physicians begin to practice medicine within an a…

Read More



Shaw & Adelman Successful Support of Lab Networks Need Hospital Leadership

CEO Summary: In the second installment of our exclusive two- part interview, the executive directors of two regional laboratory networks formed in the 1990s (one in Michigan and one in Washington State) share their assessment of why their respective lab networks have performed strongly ov…

Read More



From Modest Beginnings, Two Lab Networks Find Success

“For 20 years, our regional laboratory network here in Detroit has played an important role in helping member …

Read More



Integration of Clinical Care and the Lab Industry

DURING 2012, THE HEALTHCARE SYSTEM IN THE UNITED STATES will make measurable progress toward the goal of integrated clinical care. In my view, this will be a positive development for clinical laboratories, since it creates opportunities for labs to step up and add value to physicians, patients, and p…

Read More



2011’s Top 10 Lab Stories Point to a Busy 2012

CEO SUMMARY: Given the specific news stories that make up THE DARK REPORT’S list of the “Top Ten Lab Stories for 2011,” it might be said that 2011 was a rather quiet year overshadowed by anticipation of the coming reforms mandated by the Accountable Care Act of 2010. For the clinica…

Read More



Why Capitate Genetic and Molecular Test Prices?

HOW MANY OF YOU LIVED THROUGH THE DECADE OF THE 1990s and experienced the free fall in the prices managed care plans paid for clinical laboratory testing? In California—at the peak of this insanity—some lab companies offered full risk, capitated contracts for as low as 20¢ PMPM (per member per m…

Read More



LabCorp’s BeaconLBS Aims To Manage Genetic Tests

CEO SUMMARY: BeaconLBS is a new business created by Laboratory Corporation of America. It says it wants to help health insurance plans manage molecular diagnostics and genetic testing. BeaconLBS is now recruiting other clinical labs to join its network and is meeting with payers to offer …

Read More



Clin Lab Partners’ Strategy Is to Leverage Lab Data

CEO SUMMARY: At Clinical Laboratory Partners, the strategy is to create and deliver a growing suite of enhanced lab information services to client physicians and payers in the Connecticut market. It wants to differentiate itself from competing lab companies by packaging lab test …

Read More



Healthcare Reform and Laboratory Testing

WE ARE ONLY 120 DAYS FROM IMPLEMENTING another round of programs mandated by the Patient Protection and Affordable Care Act (PPACA) of 2010 and associated legislation. Certain programs become effective on January 1, 2012. On that date, the transition to HIPAA form 5010 takes effect. All clinical lab…

Read More



How Much Laboratory Business Intelligence Have You Missed?

Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!

Sign up for TDR Insider

Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.

;